Hermetica Superfood Encyclopedia
The Short Answer
Coscinium fenestratum contains high concentrations of the isoquinoline alkaloid berberine as its primary bioactive compound, which exerts antimicrobial, hypoglycemic, and anti-inflammatory effects principally through AMPK activation, inhibition of bacterial DNA gyrase, and downregulation of pro-inflammatory NF-κB signaling. In preclinical rodent models, methanol stem extracts at 400 mg/kg demonstrated significant reductions in blood glucose levels comparable to standard antidiabetic references, and fractionated extracts reduced mean arterial blood pressure by up to 60.6% and heart rate by 58.6% in normotensive rats.
CategoryRoot
GroupSoutheast Asian
Evidence LevelPreliminary
Primary KeywordCoscinium fenestratum benefits
Tree Turmeric — botanical close-up
Health Benefits
**Antimicrobial Activity**: Berberine and palmatine alkaloids from C
fenestratum inhibit the growth of gram-positive and gram-negative bacteria, including Staphylococcus aureus and Escherichia coli, through disruption of bacterial cell membrane integrity and inhibition of DNA gyrase enzyme function.
**Antidiabetic Effects**
Aqueous and methanol stem extracts have demonstrated significant hypoglycemic activity in streptozotocin-induced diabetic rodent models, with berberine activating AMP-activated protein kinase (AMPK) to enhance peripheral glucose uptake and suppress hepatic gluconeogenesis.
**Antioxidant Protection**
Ethanolic extracts exhibit free radical scavenging activity with a DPPH IC₅₀ of approximately 182.48 µg/mL, attributable to flavonoids (quantified at ~42 mg quercetin equivalents per gram of extract), tannins, and phenolic compounds.
**Cardiovascular and Antihypertensive Effects**
Fractionated extracts reduced mean arterial blood pressure by 60.6% and heart rate by 58.6% in experimental rat models, likely through berberine-mediated inhibition of calcium channels and modulation of adrenergic receptor signaling.
**Anti-inflammatory Activity**
Berberine within the plant suppresses NF-κB nuclear translocation and reduces downstream production of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, contributing to the traditional use in fever management.
**Antipyretic Properties**
Traditional use as a fever remedy in Thailand and Vietnam aligns with preclinical evidence showing inhibition of prostaglandin synthesis pathways, with alkaloid fractions demonstrating cyclooxygenase inhibitory potential in cell-based assays.
**Phytoestrogenic and Anabolic Potential**
The plant contains ecdysterone (20-hydroxyecdysone) at notably elevated concentrations relative to most botanical sources, a compound with evidence for anabolic signaling through estrogen receptor beta (ERβ) activation and mTOR pathway modulation.
Origin & History
Natural habitat
Coscinium fenestratum is a large woody climber native to the tropical rainforests of South and Southeast Asia, including Sri Lanka, India, Thailand, Vietnam, and Malaysia. It thrives in humid, lowland and montane forest environments, typically growing as a liana reaching up to 30 meters, preferring well-drained laterite or loamy soils with consistent moisture. The stem and root heartwood, which displays a characteristic bright yellow coloration due to high berberine content, has been harvested from wild populations for centuries, though unsustainable collection has led to its inclusion on threatened species lists in several range countries.
“Coscinium fenestratum has been documented in Ayurvedic medicine under the Sanskrit name 'Pitarajaya' and in Sinhala traditional medicine as 'Venivel,' where the bright yellow stem decoction has been used for centuries to treat fevers, jaundice, snakebite, and gastrointestinal infections. In Thai traditional medicine, it is known as 'Rang Chuet' (ระงับชืด) and appears in classical formularies as a bitter febrifuge and anti-infective, frequently combined with other alkaloid-rich plants in multi-herb formulas for malaria-like fevers and urinary tract complaints. Vietnamese traditional healers use related preparations for diabetes management and liver disorders, reflecting a parallel ethnopharmacological tradition across Indochina that predates any modern pharmacological characterization. The plant holds protected status in Sri Lanka under the Flora and Fauna Protection Ordinance due to overexploitation, and its distinctive yellow heartwood has historically also been used as a natural dye for cloth and religious artifacts in Buddhist communities throughout the region.”Traditional Medicine
Scientific Research
The evidence base for C. fenestratum consists almost entirely of in vitro cell culture studies and in vivo rodent models, with no published randomized controlled trials in human subjects identified in the peer-reviewed literature as of 2024. Preclinical antidiabetic studies using streptozotocin-induced diabetic rats have demonstrated dose-dependent hypoglycemic effects, and cardiovascular studies in normotensive rats (n typically 6–10 per group) have quantified blood pressure reductions of 45–60%, but these small animal studies cannot be directly extrapolated to clinical practice. Antimicrobial research has primarily employed agar disc diffusion and minimum inhibitory concentration (MIC) assays against laboratory bacterial strains, confirming activity but lacking pharmacokinetic data on achievable tissue concentrations in humans. The phytochemical characterization studies are reasonably well-replicated across multiple research groups in Sri Lanka, India, and Thailand, providing consistent alkaloid profiles, but the overall clinical evidence remains at the preclinical stage and the translation to human therapeutic dosing is speculative.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Stem/Root Bark)**
200–500 mL water for 15–20 minutes, consumed once or twice daily; standard preparation across Sri Lankan and Thai folk medicine for fever and digestive complaints
5–15 grams of dried stem material boiled in .
**Standardized Berberine Extract (Capsule/Tablet)**
300–500 mg berberine equivalents two to three times daily with meals
No pharmacopeial standardization specific to C. fenestratum exists; where standardized extracts are available, they are typically expressed as berberine content (≥5–10% berberine by HPLC), with extrapolated dosing from berberine research suggesting .
**Aqueous or Ethanol Tincture (1
2–4 mL per dose, two to three times daily; used in Ayurvedic and Siddha formulations under the name 'Maramanjal' or 'Pitarajaya'
5)**: .
**Powdered Stem (Raw Herb)**
1–3 grams per day in traditional contexts; yellow color of powder confirms berberine content but does not indicate potency.
**Timing Note**
Antidiabetic and cardiovascular applications in animal research used pre-meal or peri-meal dosing to coincide with postprandial glucose peaks; this timing is theoretically preferred for metabolic indications.
**Standardization Caution**
No consensus on minimum berberine content for C. fenestratum-specific products; quality control is a significant concern given species substitution risk.
Nutritional Profile
Coscinium fenestratum stem and root material is not consumed as a food and does not contribute meaningful macronutrient content in the quantities used medicinally. The dominant phytochemical constituents are isoquinoline alkaloids: berberine (the most abundant, reported at 2–5% dry weight in stem heartwood by various HPLC analyses), palmatine, jatrorrhizine, columbamine, and tetrahydroberberine. Flavonoid content has been quantified at approximately 42 mg quercetin equivalents per gram of crude extract in some studies, alongside saponins, steroids, terpenoids, tannins, and phenolic acids contributing to total antioxidant capacity. Notably, the plant contains ecdysterone (20-hydroxyecdysone) at concentrations described as high relative to most plant sources, though precise quantification varies by plant part and geographic origin. Berberine bioavailability from oral plant matrix preparations is limited by P-glycoprotein efflux and first-pass metabolism, resulting in low absolute oral bioavailability (~5% for isolated berberine), though co-presence of alkaloid synergists in whole plant preparations may modestly enhance absorption.
How It Works
Mechanism of Action
The primary bioactive alkaloid berberine activates AMP-activated protein kinase (AMPK) by increasing the AMP:ATP ratio within cells, thereby upregulating GLUT4 translocation to cell membranes to enhance glucose uptake and suppressing PEPCK and G6Pase enzyme expression to reduce hepatic glucose output. Berberine and the structurally related alkaloid palmatine intercalate into bacterial DNA and inhibit topoisomerase II (DNA gyrase), disrupting bacterial replication, while also destabilizing gram-positive cell walls through interaction with lipoteichoic acid. Anti-inflammatory activity is mediated through berberine's direct inhibition of IκB kinase (IKK), preventing IκB phosphorylation and subsequent NF-κB p65 nuclear translocation, reducing transcription of COX-2, iNOS, and pro-inflammatory cytokine genes. Ecdysterone (20E) present in C. fenestratum binds selectively to estrogen receptor beta (ERβ) and activates the PI3K/Akt/mTOR signaling cascade, contributing to protein synthesis stimulation and glucose metabolism modulation independent of the berberine pathway.
Clinical Evidence
No human clinical trials have been published for C. fenestratum as of the current literature review, representing a significant gap between its long traditional use and formal clinical validation. The most quantitatively robust preclinical data comes from cardiovascular studies in Wistar rats, where a fractionated stem extract produced mean arterial pressure reductions of 60.6% and heart rate reductions of 58.6%, though these studies did not evaluate chronic dosing safety or mechanism specificity. Antidiabetic animal studies have shown blood glucose normalization at extract doses of 200–400 mg/kg body weight, but bioavailability studies confirming that equivalent berberine concentrations are achievable in humans at practical oral doses are absent. Confidence in extrapolating any of these outcomes to clinical recommendations for human use is low; the existing evidence supports biological plausibility but does not establish efficacy or safety thresholds for supplementation.
Safety & Interactions
At doses used in traditional decoctions, C. fenestratum is generally considered tolerable in short-term use, but its high berberine content raises clinically significant interaction concerns: berberine inhibits CYP3A4, CYP2D6, and P-glycoprotein, potentially increasing plasma concentrations of co-administered drugs including cyclosporine, metformin, statins, macrolide antibiotics, and anticoagulants such as warfarin. Berberine is absolutely contraindicated in pregnancy due to documented uterotonic effects and potential fetal bilirubin displacement causing neonatal jaundice; it is also contraindicated in neonates and infants and should be avoided during lactation. At high doses, berberine-rich extracts may cause gastrointestinal disturbances including nausea, cramping, and constipation, and can potentiate hypoglycemia when combined with insulin or oral antidiabetic agents requiring careful blood glucose monitoring. No formal maximum tolerable dose has been established for C. fenestratum preparations specifically, and the absence of human safety trials means that chronic high-dose use carries uncharacterized risks; individuals with hepatic or renal impairment should use with medical supervision given the alkaloid load.
Synergy Stack
Hermetica Formulation Heuristic
Featured in
Cozy
Warming adaptogenic blend for comfort and calm.
Shop Now →
Also Known As
Coscinium fenestratumCoscinium usitatum (erroneous synonym)Venivel (Sinhala)Rang Chuet (Thai)Maramanjal (Tamil)Pitarajaya (Sanskrit)Tree TurmericFalse Calumba
Frequently Asked Questions
What is the main active compound in Coscinium fenestratum and what does it do?
The primary bioactive compound is berberine, an isoquinoline alkaloid present at approximately 2–5% dry weight in the stem heartwood. Berberine activates AMP-activated protein kinase (AMPK), inhibits bacterial DNA gyrase, and suppresses NF-κB inflammatory signaling, explaining the plant's traditional uses in fever, infection, and blood sugar management.
Can Coscinium fenestratum help lower blood sugar levels?
Preclinical rodent studies using streptozotocin-induced diabetic models have demonstrated significant blood glucose reductions at extract doses of 200–400 mg/kg body weight, with berberine's AMPK activation mechanism enhancing GLUT4-mediated glucose uptake. However, no human clinical trials have been conducted, so it cannot currently be recommended as a clinically validated antidiabetic treatment.
Is Coscinium fenestratum the same as turmeric or berberine supplements?
Despite the common name 'tree turmeric,' C. fenestratum is botanically unrelated to culinary turmeric (Curcuma longa) and belongs to the family Menispermaceae. It is a distinct berberine source, separate from more commonly supplemented berberine-rich plants such as Berberis vulgaris (barberry) or Hydrastis canadensis (goldenseal), though all share the same primary alkaloid.
What are the safety concerns and drug interactions for Coscinium fenestratum?
The high berberine content means significant drug interactions are possible: berberine inhibits CYP3A4 and CYP2D6 enzymes, raising blood levels of statins, cyclosporine, warfarin, and metformin. It is contraindicated in pregnancy due to uterotonic effects and risk of neonatal jaundice, and should be used cautiously alongside any hypoglycemic medications due to additive blood sugar-lowering effects.
What is the traditional preparation method and typical dose used in Southeast Asian medicine?
Traditional preparations involve boiling 5–15 grams of dried C. fenestratum stem or root bark in approximately 500 mL of water for 15–20 minutes to produce a yellow decoction, consumed once or twice daily for fevers, liver complaints, and infections. Modern standardized extracts are not well-established for this specific species, and dosing guidance based on berberine content (300–500 mg berberine equivalents per dose) is extrapolated from research on other berberine-rich plants rather than C. fenestratum-specific clinical data.
Does Coscinium fenestratum have antimicrobial or antibacterial properties?
Yes, Coscinium fenestratum contains alkaloids like berberine and palmatine that demonstrate significant antimicrobial activity against both gram-positive and gram-negative bacteria, including common pathogens such as Staphylococcus aureus and Escherichia coli. These alkaloids work by disrupting bacterial cell membrane integrity and inhibiting DNA gyrase, an enzyme essential for bacterial DNA replication. This antimicrobial action may support immune function and help prevent certain bacterial infections, though more human clinical trials are needed to establish therapeutic efficacy.
What is the difference between Coscinium fenestratum extract forms and which is most studied?
Coscinium fenestratum is available as dried root powder, aqueous extracts, and methanol extracts, with aqueous and methanol stem extracts being the most studied forms in research demonstrating antidiabetic and antimicrobial effects. Aqueous extracts are traditionally prepared and may offer better safety profiles, while methanol extracts tend to concentrate alkaloid content but are less commonly used in traditional practice. The choice between forms depends on intended use, with traditional Southeast Asian preparations typically favoring water-based decoctions for digestive and metabolic support.
Who should consider taking Coscinium fenestratum supplements and who should avoid it?
Individuals with elevated blood sugar levels, metabolic concerns, or recurrent bacterial infections may benefit from Coscinium fenestratum supplementation based on traditional use and preliminary research. However, those taking diabetes medications, antibiotics, or with liver conditions should avoid this ingredient without medical supervision due to potential interactions and the liver's role in processing its alkaloid compounds. Pregnant women, nursing mothers, and individuals with known allergies to Ranunculaceae family plants should consult healthcare providers before use.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w coscinium-fenestratum-tree-turmeric curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
